| ๐ท๏ธย Parameter | ๐ย Details |
|---|---|
| ๐งฌ Active Ingredient | Venlafaxine (Extended-Release) |
| ๐ Indication | Major Depressive Disorder, Generalized Anxiety, Panic Disorder, Social Anxiety |
| ๐บ๐ธ US Brand | Effexor XRยฎ |
| ๐ญ Manufacturer | Cipla Ltd. |
| ๐ฆ Packaging | Strips of 10 capsules |
| ๐ช Strength | 37.5 mg, 75 mg, 150 mg |
| ๐ Delivery Time | 7โ14 days (Worldwide) |
๐ง Introduction to Venlor XR
Venlor XR by Cipla containsย Venlafaxine, a serotonin-norepinephrine reuptake inhibitor (SNRI) in extended-release capsules. Key features:
-
โณย Once-daily dosing: Maintains stable plasma concentrations
-
๐ย Dual mechanism: Inhibits reuptake of serotonin (low dose) and norepinephrine (โฅ75mg)
-
โ ๏ธย Black-box warning: Increased suicidality in young adults
-
โย High discontinuation syndrome riskย (avoid abrupt stoppage)
Cipla’s 10-capsule strips ensure accurate dosing for conditions like treatment-resistant depression and generalized anxiety disorder (GAD).
๐ Dosage & Indications
| ๐ย Indication | ๐งชย Dosage | โฑ๏ธย Frequency | ๐กย Notes |
|---|---|---|---|
| Major Depression | Start 75mg โ Max 225mg/day | Once daily | Take with food |
| Generalized Anxiety | 37.5-150mg/day | Once daily | Morning dose |
| Panic Disorder | Start 37.5mg โ 75-225mg/day | Once daily | Titrate weekly |
| Renal/Hepatic Impairment | Reduce dose by 50% | โ | Avoid in severe cases |
โ ๏ธ Side Effects, Storage & Warnings
-
โ Common Side Effects:
-
Nausea (35%)
-
Headache (25%)
-
Insomnia (18%)
-
Hypertension (12% at >150mg/day)
-
-
๐ซ Serious Risks:
-
Suicidal ideation (age <24)
-
Serotonin syndrome
-
Angle-closure glaucoma
-
-
โ๏ธ Storage: 15-30ยฐC; protect from moisture (keep in original strip).
-
โ ๏ธ Critical Warnings:
-
Monitor BP weeklyย for first 3 months
-
Taper gradually (reduce by 75mg/week)
-
Contraindicated with MAOIs (14-day washout)
-
๐ Global Availability & Shipping
| ๐ย Region | ๐ฆย Shipping | ๐ตย Price (10-capsule strip) | ๐ย Prescription |
|---|---|---|---|
| ๐บ๐ธ USA | โ Yes | $20โ$40 | Required |
| ๐ฌ๐ง UK | โ Yes | ยฃ15โยฃ30 | Required |
| ๐ฆ๐บ Australia | โ Yes | AUD 25โ45 | Required |
๐ Related Indian Alternatives (Different in Same Category)
| ๐ Product Name | ๐ญ Manufacturer | ๐ Internal Link |
|---|---|---|
| Etilaam (Etizolam) | Intas | etilaam |
| Nexito (Escitalopram) | Sun Pharma | nexito |
| Zosert (Sertraline) | Sun Pharma | zosert |
| Prodep (Fluoxetine) | Sun Pharma | prodep |
| Mirtaz (Mirtazapine) | Intas | mirtaz |
| Dulane (Duloxetine) | Cipla | dulane |
๐ External Medical References
๐ฉบ Expert Commentary
Dr. Sameer Verma, Psychiatrist:
“Venlor XR’s dual SNRI action makes it effective for depression with fatigue, but monitor BP diligently at doses >150mg. For elderly patients, [nexito] (Escitalopram) has fewer interactions. Cipla’s capsules have ‘CIPLA’ printed on them โ never crush or chew.”
๐ Disclaimer
This information is not medical advice. Use under physician supervision. Ciplaโs Venlor XR carries black-box warnings for suicidality.
๐ก Clinical Protocol:
-
Dosing Strategy:
Condition Starting Dose Therapeutic Range Titration Depression 75mg 150-225mg +75mg/week GAD 37.5mg 75-150mg +37.5mg/week -
Discontinuation Syndrome Management:
Symptom Action Dizziness Reduce by 37.5mg every 4 days “Brain zaps” Short-term benzodiazepine bridge Severe symptoms Reinstate dose + slower taper -
Capsule Identification:
-
37.5mg: Yellow cap/body
-
75mg: Orange cap/body
-
150mg: Burnt orange cap/body
-
-
Drug Interactions:
Concomitant Drug Risk Action SSRIs/TCAs โ Serotonin syndrome risk Avoid NSAIDs โ Bleeding risk Monitor for bruising Warfarin โ INR Frequent INR checks -
Hypertension Monitoring:
-
Baseline BP โ Weekly ร1 month โ Monthly thereafter
-
Discontinue if BP >140/90 mmHg unresponsive to antihypertensives
-






Reviews
There are no reviews yet.